How Upgraded Guidance and Capital Returns at Viatris (VTRS) Have Changed Its Investment Story [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
and increasing anticipated adjusted earnings per share, supported by contributions from new products and the acquisition of Aculys Pharma. Management emphasized its ongoing pursuit of growth-focused mergers and acquisitions, while also reaffirming a commitment to shareholder returns through dividends and share repurchases exceeding US$920 million year-to-date. We'll explore how Viatris's upgraded financial guidance and increased capital returns influence the company's investment narrative moving forward. AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early. Viatris Investment Narrative Recap To own Viatris stock, you have to believe in the company's ability to offset slow-growing, off-patent drug sales with new product launches, accretive acquisitions, and operational efficiency. The raised 2025 guidance and solid Q3 res
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- What Do Recent Portfolio Streamlining Moves Mean for Viatris's True Value in 2025? [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in Upcoming Investor ConferencesPR Newswire
- Looking at the Changing Narrative for Idorsia After Recent Analyst and Market Developments [Yahoo! Finance]Yahoo! Finance
- European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for EuropePR Newswire
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 11/10/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- VTRS's page on the SEC website